Atezolizumab and bevacizumab as first line therapy in advanced hepatocellular carcinoma: Practical considerations in routine clinical practice
Citation
Jain, A, Chitturi, S, Peters, G et al. 2021, 'Atezolizumab and bevacizumab as first line therapy in advanced hepatocellular carcinoma: Practical considerations in routine clinical practice', World Journal of Hepatology, vol. 13, no. 9, pp. 1132-1142.